DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
NCT ID: NCT00389779
Last Updated: 2014-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
849 participants
INTERVENTIONAL
2006-09-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
NCT00330369
A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs
NCT00364026
The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
NCT02433119
Phase III Study to Evaluate the Efficacy and Safety of AD-209
NCT06348576
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Darusentan
Placebo to match darusentan for 2-week placebo run-in period, followed by darusentan capsules titrated to an optimal dose of 50 mg, 100 mg, or 300 mg administered orally once daily for 14 weeks
Darusentan
Darusentan capsules administered orally once daily
Darusentan Placebo
Placebo to match darusentan administered orally once daily
Guanfacine
Placebo to match darusentan for 2-week placebo run-in period, followed by guanfacine 1 mg capsules administered orally once daily for 14 weeks
Guanfacine
Guanfacine capsules administered orally once daily
Darusentan Placebo
Placebo to match darusentan administered orally once daily
Darusentan Placebo
Placebo to match darusentan for 2-week placebo run-in period, followed by placebo to match darusentan administered orally once daily for 14 weeks
Darusentan Placebo
Placebo to match darusentan administered orally once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Darusentan
Darusentan capsules administered orally once daily
Guanfacine
Guanfacine capsules administered orally once daily
Darusentan Placebo
Placebo to match darusentan administered orally once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged 35 to 80 years;
3. Subjects with diabetes and/or chronic kidney disease must have an average sitting systolic blood pressure greater than or equal to 130 mmHg;
4. All other subjects must have an average sitting systolic blood pressure greater than or equal to 140 mmHg;
5. Receiving and adhering to full doses of appropriate guideline-recommended antihypertensive drugs from three different classes of antihypertensive agents, including a diuretic;
6. Female subjects of non-childbearing potential (i.e., post-menopausal for at least 2 years or surgically sterile).
Exclusion Criteria
2. Subjects treated with a central alpha-2 agonist and/or imidazoline receptor agonist;
3. Left ventricular dysfunction;
4. Serum ALT or AST greater than 2 times the Upper Limit of Normal;
5. Subjects who have experienced myocardial infarction, unstable angina pectoris, or a cerebrovascular accident within 6 months; or sick sinus syndrome or second or third degree atrioventricular block, atrial fibrillation or recurrent atrial tachycardia, recurrent ventricular tachycardia, or symptomatic bradycardia;
6. Implanted pacemakers or cardioverter defibrillator;
7. Symptomatic congestive heart failure requiring treatment;
8. Hemodynamically significant valvular heart disease;
9. Hemodialysis or peritoneal dialysis, or history of renal transplant;
10. Type I diabetes mellitus;
11. Diagnosis or recurrence of malignancy within the past 3 years;
12. Sleep apnea, unless a recent sleep study demonstrated arterial oxygenation saturation greater than or equal to 90%, treated or untreated;
13. Subjects who perform alternating shift or night work;
14. Subjects who have participated in a clinical study involving another investigational drug or device within 4 weeks prior to Screening
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Internal Medicine, PC
Birmingham, Alabama, United States
Greystone Medical Research, LLC
Birmingham, Alabama, United States
The Heart Center, PC
Huntsville, Alabama, United States
Mulberry Medical Associates, PC
Montgomery, Alabama, United States
Arizona Center for Clinical Research
Glendale, Arizona, United States
Cardiovascular Consultants, Ltd.
Glendale, Arizona, United States
Lovelace Scientific Resources, Inc
Phoenix, Arizona, United States
Cochise Clinical Research
Sierra Vista, Arizona, United States
Southwest Heart
Tucson, Arizona, United States
HealthFirst Physician of AR, PA dba Convenient Care Clinic
Hot Springs, Arkansas, United States
NEA Clinic
Jonesboro, Arkansas, United States
Arkansas Primary Care Clinic, PA
Little Rock, Arkansas, United States
Medical Investigations Inc.
Little Rock, Arkansas, United States
Highgrove Medical Center
Bakersfield, California, United States
Central Cardiology Medical Clinic
Bakersfield, California, United States
Impact Clinical Trials
Beverly Hills, California, United States
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States
Rancho Cucamonga Clinical Trials
Rancho Cucamonga, California, United States
Pacific Heart Institute
Santa Monica, California, United States
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Doctors Medical Center of Walton County
DeFuniak Springs, Florida, United States
Broward General Medical Center
Fort Lauderdale, Florida, United States
Maxine Hamilton, MD, PA
Fort Lauderdale, Florida, United States
St. John's Center for Clinical Research
Jacksonville, Florida, United States
Private Practice of Dr. Bridget Bellingar
Largo, Florida, United States
A+ Research Inc.
Miami, Florida, United States
AppleMed Research, Inc.
Miami, Florida, United States
Internal Medicine Associates of South Florida
North Miami Beach, Florida, United States
Ormond Medical Arts Pharmaceutical Research center
Ormond Beach, Florida, United States
Northwest Florida Heart Group, PA - Research Dept
Pensacola, Florida, United States
Cardiovascular Center of Sarasota
Sarasota, Florida, United States
Suncoast Cardiovascular Research, Inc.
St. Petersburg, Florida, United States
Tampa Bay Nephrology Associates, PL
Tampa, Florida, United States
Orlando Rangel, MD, PA
Tampa, Florida, United States
Medical College of Georgia
Augusta, Georgia, United States
AMR Research Associates, LLC
Bogart, Georgia, United States
Atlanta Vascular Research Foundation
Tucker, Georgia, United States
North Shore Cardiologist
Bannockburn, Illinois, United States
Consultants in Cardiovascular Med (CIS)
Melrose Park, Illinois, United States
Illinois Heart & Lunch Research
Normal, Illinois, United States
Methodist Medical Center-Heart, Lung & Vascular Institute
Peoria, Illinois, United States
Medical Consultants, PC
Muncie, Indiana, United States
University Medical Associates
Louisville, Kentucky, United States
Dr. Jeffrey Chen
Lafayette, Louisiana, United States
Louisiana Research Associates, Inc
New Orleans, Louisiana, United States
Maine Research Associate
Auburn, Maine, United States
PrimeCare Internal Medicine
Biddeford, Maine, United States
Great Lakes Heart Center of Alpena
Alpena, Michigan, United States
Internal Medicine of Nothern Michigan
Petoskey, Michigan, United States
Minneapolis VAMC
Minneapolis, Minnesota, United States
Central Minnesota Heart Center at St. Cloud Hospital
Saint Cloud, Minnesota, United States
St. Paul Cardiology
Saint Paul, Minnesota, United States
Glacier View Cardiology, PC
Kalispell, Montana, United States
Impact Clinical Trials
Las Vegas, Nevada, United States
NJ Heart
Linden, New Jersey, United States
New Jersey Physicians
Passaic, New Jersey, United States
Lifeline Research Institute
Brooklyn, New York, United States
Metrolina Internal Medicine, PA
Charlotte, North Carolina, United States
Heart Care Center of Charlotte
Charlotte, North Carolina, United States
Physicians East, PA
Winterville, North Carolina, United States
Plaza Medical Group, PC
Oklahoma City, Oklahoma, United States
Castlerock Clinical Research Counsultants, LLC
Tulsa, Oklahoma, United States
Integrated Medical Research PC
Ashland, Oregon, United States
Blackstone Cardiology Associates
Pawtucket, Rhode Island, United States
Charleston Cardiology
Charleston, South Carolina, United States
Paris View Family Practice
Greenville, South Carolina, United States
Internal Medicine of Greer
Greer, South Carolina, United States
Scenic City Research
Cleveland, Tennessee, United States
Southeast Texas Clinical Research Center
Beaumont, Texas, United States
Cardiovascular Research Inst. of Dallas
Dallas, Texas, United States
Galenos Research
Dallas, Texas, United States
Sergio F Rovner, MD
El Paso, Texas, United States
Salim Gopalani, MD, PA
Houston, Texas, United States
Humayun Mirza, MD, PA
Houston, Texas, United States
Clinical Trial Network
Houston, Texas, United States
Houston Clinical Research Assoc.
Houston, Texas, United States
Innovative Research of West Florida
Hurst, Texas, United States
North Texas Medical Research
Plano, Texas, United States
Scott & White Memorial Hospital
Temple, Texas, United States
Fletcher Allen Health Care/University of Vermont
Burlington, Vermont, United States
Kamlesh N. Dave Cardiology
Hopewell, Virginia, United States
WVU Physicians of Charleston
Charleston, West Virginia, United States
Alpha Medical Research, LLC
Madison, Wisconsin, United States
Executive Health and Research Associates
Madison, Wisconsin, United States
Hospital Italiano Regional del Sur
Bahía Blanca, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Bahia Blanca
Bahía Blanca, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
Consultorios Medicos Privados S.A.
Buenos Aires, , Argentina
Hospital General de Agudos "Dr. Abel Zubizarreta"
Buenos Aires, , Argentina
Policlinica Bancaria "9 de Julio"
Buenos Aires, , Argentina
Diabaid (Instituto de Asistencia Integral en Diabetes)
Ciudad de Buenos Aires, , Argentina
MD Investigaciones
Ciudad de Buenos Aires, , Argentina
Centro Medico Privado
Ciudad de, , Argentina
Instituto de Cardiologia de Corrientes
Corrientes, , Argentina
Fundacion Rusculleda
Córdoba, , Argentina
Framingham Centro Medico
La Plata, , Argentina
Instituto de Investigaciones Clinicas de Quilmes
Quilmes, , Argentina
Instituto de Investigaciones Clinicas
Rosario, , Argentina
Centro de Investigaciones Clinicas del Litoral
Santa Fe, , Argentina
Flinders Medical Centre
Bedford Park, , Australia
Royal Brisbane & Women's Hospital
Herston, , Australia
Alfred Hospital
Melbourne, , Australia
Royal Perth Hospital
Perth, , Australia
U.Z. Brussel
Brussels, , Belgium
Private Practice of Dr. Geert Hollanders
De Pinte, , Belgium
Private Practice of Dr. Francis Vrancken
Genk, , Belgium
Private Practice of Dr. Herwig Van Aerde
Genk, , Belgium
Private Practice of Dr. Willy Denier
Genk, , Belgium
Private Practice of Dr. Herman Docx
Hoeilaart, , Belgium
Private Practice of Dr. Yohan Balthazar
Natoye, , Belgium
Private Practice of Dr. Sophie Baeyens
Pulle, , Belgium
Private Practice of Dr. Jean Gilissen
Riemst, , Belgium
Private Practice of Dr. Guido Mehuys
Tielt, , Belgium
Private Practice of Dr. Luc Capiau
Wetteren, , Belgium
Hospital Universitario Pedro Ernesto
Rio de Janeiro, , Brazil
Aalborg University Hospital
Aalborg, , Denmark
Region Sjaelland, Storstrommens Sygenhus, Naestved
Næstved, , Denmark
Private Practice of dr. Marty Jacques
Mûrs-Erigné, Murs-Erigne, France
George Delamare
Blois, , France
Centre d'Investigation Clinique
Dommartin-lès-Toul, , France
Private Practice of Dr. Brune Charrier
La Jubaudière, , France
Private Practice of Dr. Jean Boulet-Gercourt
Le Mesnil-en-Vallée, , France
Private Practice of Dr. Gildas Ganuchaud
Le Temple-de-Bretagne, , France
Private Practice of Dr. Jacques Samat
Martigues, , France
Private Practice of Dr. Alain Boye
Nantes, , France
Private Practice of Dr. Francois Volny
Nantes, , France
Private Practice of Dr. Thierry Schaupp
Vihiers, , France
Private Practice of Dr. Josef Junggeburth
Bad Wörishofen, , Germany
Charite Campus Mitte, Universitatsmedizin Berlin
Berlin, , Germany
Klinische Forschung Berlin-Buch GmbH
Berlin, , Germany
Private Practice of Dr. Isabelle Schenkenberger
Berlin, , Germany
Private Practice of Dr. Tobias Marsen
Cologne, , Germany
PD Dr. med. Bernhard Winkelmann
Frankfurt, , Germany
Clinical Research Hamburg
Hamburg, , Germany
Dr. Med. Susanne Mindt-Prufert
Hamburg, , Germany
Private Practice for Internal Medicine & Cardiology
Heidelberg, , Germany
IFG-Institut fur Gesundheitsforderung GmbH
Rüdersdorf, , Germany
Centre for Clinical Research and Effective Practice (CCRep)
Auckland, , New Zealand
Christchurch Hospital
Christchurch, , New Zealand
Greenlane Clinical Centre
Greenlane, , New Zealand
Cardiology Clinical Trial Unit
Hamilton, , New Zealand
Tauranga Hospital
Tauranga, , New Zealand
Hospital Universitario de Bellvitge
Barcelona, , Spain
Hospital General Universitario de Elche
Elche, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, Arterburn S, Sager P, Weber M. Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension. 2010 Nov;56(5):824-30. doi: 10.1161/HYPERTENSIONAHA.110.156976. Epub 2010 Oct 4.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol DAR-312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.